Preface to the Special Issue: Integrated omics

Journal of Proteomics

Volumn 76, Issue , 2012, Pages 3-9

  Zolla, Lello ^a   D'Alessandro, Angelo ^a  

^a UNIVERSITY OF TUSCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PHOSPHOPROTEIN; SERUM AMYLOID A; THROMBOCYTE CONCENTRATE;

BLOOD; EDITORIAL; ERYTHROCYTE; GLYCOBIOLOGY; HEALTH CARE SYSTEM; HUMAN; IRON METABOLISM; METABOLOMICS; MOLECULAR WEIGHT; NEUROPATHY; OXIDATIVE STRESS; PLASMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEOMICS; SCHIZOPHRENIA;

ANIMALS; BIOLOGICAL MARKERS; HUMANS; PROTEOME; PROTEOMICS;

EID: 84869878884     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.10.007     Document Type: Editorial

References (34)

1. Polati R., Castagna A., Bossi A.M., Alberio T., De Domenico I., Kaplan J., et al. Murine macrophages response to iron. J Proteomics 2012, 10.1016/j.jprot.2012.07.018.
2. Campostrini N., Traglia M., Martinelli N., Corbella M., Cocca M., Manna D., et al. Serum levels of the hepcidin-20 isoform in a large general population: the Val Borbera study. J Proteomics Aug 21 2012, 10.1016/j.jprot.2012.08.006.
3. Jaros J.A., Guest P.C., Ramoune H., Rothermundt M., Leweke F.M., Martins-de-Souza D., et al. Clinical use of phosphorylated proteins in blood serum analysed by immobilised metal ion affinity chromatography and mass spectrometry. J Proteomics 2012, 10.1016/j.jprot.2012.02.015.
4. Jaros J.A., Martins-de-Souza D., Rahmoune H., Rothermundt M., Leweke F.M., Guest P.C., et al. Protein phosphorylation patterns in serum from schizophrenia patients and healthy controls. J Proteomics 2012, 10.1016/j.jprot.2012.05.027.
5. Srivastava R., Ray S., Vaibhav V., Gollapalli K., Jhaveri T., Taur S., et al. Serum profiling of leptospirosis patients to investigate proteomic alterations. J Proteomics 2012, 10.1016/j.jprot.2012.04.007.
6. Hjelle S.M., Sulen A., Oye O.K., Jørgensen K., McCormack E., Hollund B.E., et al. Leukocyte p53 protein biosignature through standard-aligned two-dimensional immunoblotting. J Proteomics 2012, 10.1016/j.jprot.2012.07.021.
7. Rucevic M., Rosenquist T., Breen L., Cao L., Clifton J., Hixson D., et al. Proteome alterations in response to aristolochic acids in experimental animal model. J Proteomics 2012, 10.1016/j.jprot.2012.06.026.
8. Milan E., Lazzari C., Anand S., Floriani I., Torri V., Sorlini C., et al. SAA1 is over-expressed in plasma of non small cell lung cancer patients with poor outcome after treatment with epidermal growth factor receptor tyrosine-kinase inhibitors. J Proteomics 2012, 10.1016/j.jprot.2012.06.022.
9. Luna Coronell J.A., Syed P., Sergelen K., Gyurján I., Weinhäusel A. The current status of cancer biomarker research using tumour-associated antigens for minimal invasive and early cancer diagnostics. J Proteomics 2012, 10.1016/j.jprot.2012.07.022.
10. Malm J., Végvári A., Rezeli M., Upton P., Danmyr P., Nilsson R., et al. Large scale biobanking of blood-the importance of high density sample processing procedures. J Proteomics 2012, 10.1016/j.jprot.2012.05.003.
11. Gianazza E., Chinello C., Mainini V., Cazzaniga M., Squeo V., Albo G., et al. Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors. J Proteomics 2012, 10.1016/j.jprot.2012.07.032.
12. Mathivanan S., Ji H., Tauro B.J., Chen Y.S., Simpson R.J. Identifying mutated proteins secreted by colon cancer cell lines using mass spectrometry. J Proteomics 2012, 10.1016/j.jprot.2012.06.031.
13. Haudek-Prinz V.J., Klepeisz P., Slany A., Griss J., Meshcheryakova A., Paulitschke V., et al. Proteome signatures of inflammatory activated primary human peripheral blood mononuclear cells. J Proteomics 2012, 10.1016/j.jprot.2012.07.012.
14. Paglia G., Palsson B.O., Sigurjonsson O.E. Systems biology of stored blood cells: can it help to extend the expiration date?. J Proteomics 2012, 10.1016/j.jprot.2012.08.014.
15. Gevi F., D'Alessandro A., Rinalducci S., Zolla L. Alterations of red blood cell metabolome during cold liquid storage of erythrocyte concentrates in CPD-SAGM. J Proteomics 2012, 10.1016/j.jprot.2012.03.012.
16. Delobel J., Prudent M., Rubin O., Crettaz D., Tissot J.D., Lion N. Subcellular fractionation of stored red blood cells reveals a compartment-based protein carbonylation evolution. J Proteomics 2012, 10.1016/j.jprot.2012.05.004.
17. Pesciotta E.N., Sriswasdi S., Tang H.Y., Mason P.J., Bessler M., Speicher D.W. A label-free proteome analysis strategy for identifying quantitative changes in erythrocyte membranes induced by red cell disorders. J Proteomics 2012, 10.1016/j.jprot.2012.08.010.
18. Bosman G.J., Lasonder E., Groenen-Döpp Y.A., Willekens F.L., Werre J.M. The proteome of erythrocyte-derived microparticles from plasma: new clues for erythrocyte aging and vesiculation. J Proteomics 2012, 10.1016/j.jprot.2012.05.031.
19. Sparrow R.L., Chan K.S. Microparticle content of plasma for transfusion is influenced by the whole blood hold conditions: pre-analytical considerations for proteomic investigations. J Proteomics 2012, 10.1016/j.jprot.2012.07.013.
20. Antonelou M.H., Tzounakas V.L., Velentzas A.D., Stamoulis K.E., Kriebardis A.G., Papassideri I.S. Effects of pre-storage leukoreduction on stored red blood cells signaling: a time-course evaluation from shape to proteome. J Proteomics 2012, 10.1016/j.jprot.2012.06.032.
21. Chaichompoo P., Kumya P., Khowawisetsut L., Chiangjong W., Chaiyarit S., Pongsakul N., et al. Characterizations and proteome analysis of platelet-free plasma-derived microparticles in β-thalassemia/hemoglobin E patients. J Proteomics 2012, 10.1016/j.jprot.2012.06.004.
22. Pantaleo A., Ferru E., Carta F., Valente E., Pippia P., Turrini F. Effect of heterozygous beta thalassemia on the phosphorylative response to Plasmodium falciparum infection. J Proteomics Sep 1 2012, S1874-3919(12)00636-7. 10.1016/j.jprot.2012.08.018.
23. Alexandre B.M., Charro N., Blonder J., Lopes C., Azevedo P., Bugalho de Almeida A., et al. Profiling the erythrocyte membrane proteome isolated from patients diagnosed with chronic obstructive pulmonary disease. J Proteomics 2012, 10.1016/j.jprot.2012.04.008.
24. Rebulla P. From pH to MALDI-TOF: hundreds of spotted opportunities?. J Proteomics 2012, 10.1016/j.jprot.2012.07.044.
25. Parguina A.F., Rosa I., Garcia A. Proteomics applied to the study of platelet-related diseases: aiding the discovery of novel platelet biomarkers and drug targets. J Proteomics 2012, 10.1016/j.jprot.2012.04.043.
26. Shai E., Rosa I., Parguiña A.F., Motahedeh S., Varon D., García A. Comparative analysis of platelet-derived microparticles reveals differences in their amount and proteome depending on the platelet stimulus. J Proteomics 2012, 10.1016/j.jprot.2012.02.030.
27. Thiele T., Iuga C., Janetzky S., Schwertz H., Gesell Salazar M., Fürll B., et al. Early storage lesions in apheresis platelets are induced by the activation of the integrin αII(b)β(3) and focal adhesion signaling pathways. J Proteomics 2012, 10.1016/j.jprot.2012.04.057.
28. Prudent M., Crettaz D., Delobel J., Tissot J.D., Lion N. Proteomic analysis of intercept-treated platelets. J Proteomics 2012, 10.1016/j.jprot.2012.07.008.
29. Schubert P., Culibrk B., Karwal S., Slichter S.J., Devine D.V. Optimization of platelet concentrate quality: application of proteomic technologies to donor management. J Proteomics 2012, 10.1016/j.jprot.2012.06.023.
30. D'Alessandro A., Giardina B., Gevi F., Timperio A.M., Zolla L. Clinical Metabolomics: the next stage of clinical biochemistry. Blood Transfus 2012, 10(2):s19-s24.
31. Prudent M., Tissot J.D., Lion N. Proteomics of blood and derived products: what's next?. Expert Rev Proteomics 2011, 8(6):717-737.
32. Devine D.V., Schubert P. Proteomic applications in blood transfusion: working the jigsaw puzzle. Vox Sang 2011, 100(1):84-91.
33. D'Alessandro A., Zolla L. Proteomics for quality-control processes in transfusion medicine. Anal Bioanal Chem 2010, 398(1):111-124.
34. Thiele T., Steil L., Völker U., Greinacher A. Transfusion medicine and proteomics. Alliance or coexistence?. Blood Transfus 2010, 8(3):s16-s25.